Paeoniflorin Attenuates Gestational Diabetes Via Akt/mTOR Pathway in a Rat Model

Overview

Journal Food Nutr Res

Specialty Nutritional Sciences

Date 2020 Nov 26

PMID 33240030

Citations 6

Authors

Yonghua Zhang

Yulin Liang

Huiqiao Liu

Ying Huang

Hongmei Li

Bo Chen

Affiliations

Soon will be listed here.

Abstract

Background: Gestational diabetes mellitus (GDM) is a type of diabetes associated with pregnancy and may impose risks on both mother and fetus. Akt paeoniflorin was shown to have anti-inflammatory and anti-hyperglycemia properties and has a potential ability to suppress mammalian target of rapamycin (mTOR) signaling. The current study aimed to study the effect of paeoniflorin on GDM maternal, fetal, and placental characteristics .

Methods: Streptozotocin (STZ)-induced gestational diabetes rat model was used in our study. The expression levels of phosphorylation (p-) and total protein expression levels of protein kinase B (Akt), mTOR, serum/glucocorticoid regulated kinase 1 (SGK1), and eIF4E-binding protein 1 (4E-BP1) in the placenta were determined by Western blot assay. The blood glucose, insulin, and leptin levels were assessed using enzyme-linked immunosorbent assay (ELISA).

Results: We found that placental Akt/mTOR signaling was substantially upregulated in GDM patients compared with healthy donors. Paeoniflorin administration alleviates the dysregulation of blood glucose, leptin, and insulin levels in both maternal and fetal GDM rats. Paeoniflorin treatment suppressed the overactivation of Akt/mTOR signaling in placental tissues. More importantly, administration of paeoniflorin was beneficial for normalization of fetal size and body weight in the GDM rats.

Conclusion: Our study suggested that application of paeoniflorin may serve as a potential therapeutical strategy for patients with GDM.

Citing Articles

Using Network Pharmacology and in vivo Experiments to Uncover the Mechanisms of Radix Paeoniae Rubra and Radix Angelicae Sinensis Granules in Treating Diabetes Mellitus-Induced Erectile Dysfunction.

Wang J, Guo Y, Huang J, Yan J, Ma J Drug Des Devel Ther. 2024; 18:6243-6262.

PMID: 39735336 PMC: 11682668. DOI: 10.2147/DDDT.S493198.

Association between serum branched chain amino acids, mammalian target of rapamycin levels and the risk of gestational diabetes mellitus: a 1:1 matched case control study.

Cui L, Li Z, Liu X, Li Z, Li J, Guo Y BMC Pregnancy Childbirth. 2024; 24(1):633.

PMID: 39358711 PMC: 11446021. DOI: 10.1186/s12884-024-06815-2.

Paeoniflorin alleviates high glucose-induced endothelial cell apoptosis in diabetes mellitus by inhibiting HRAS-activated RAS pathway.

Yu W, Jiang H Endocr J. 2024; 71(11):1045-1053.

PMID: 39085078 PMC: 11778359. DOI: 10.1507/endocrj.EJ24-0122.

STZ-induced gestational diabetes exposure alters PTEN/AKT/mTOR-mediated autophagy signaling pathway leading to increase the risk of neonatal hypoxic-ischemic encephalopathy.

Gong L, Jiang S, Tian J, Li Y, Yu W, Zhang L Reprod Toxicol. 2024; 123.

PMID: 38706688 PMC: 11068333. DOI: 10.1016/j.reprotox.2023.108494.

Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy.

Yao P, Liu Y Molecules. 2023; 28(1).

PMID: 36615471 PMC: 9822439. DOI: 10.3390/molecules28010272.

References

Laplante M, Sabatini D . mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93. PMC: 3331679. DOI: 10.1016/j.cell.2012.03.017. View

Fahlbusch F, Hartner A, Menendez-Castro C, Nogel S, Marek I, Beckmann M . The placental mTOR-pathway: correlation with early growth trajectories following intrauterine growth restriction?. J Dev Orig Health Dis. 2015; 6(4):317-26. DOI: 10.1017/S2040174415001154. View

Gong W, Lin J, Niu Q, Wang H, Zhou Y, Chen S . Paeoniflorin diminishes ConA-induced IL-8 production in primary human hepatic sinusoidal endothelial cells in the involvement of ERK1/2 and Akt phosphorylation. Int J Biochem Cell Biol. 2015; 62:93-100. DOI: 10.1016/j.biocel.2015.02.017. View

Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen E, Clausen T . Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016; 59(7):1396-1399. DOI: 10.1007/s00125-016-3985-5. View

Weichhart T . Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life. Methods Mol Biol. 2011; 821:1-14. DOI: 10.1007/978-1-61779-430-8_1. View

Yang X, Yang C, Farberman A, Rideout T, de Lange C, France J . The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth. J Anim Sci. 2007; 86(14 Suppl):E36-50. DOI: 10.2527/jas.2007-0567. View

Barlow A, Nicholson M, Herbert T . Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms. Diabetes. 2013; 62(8):2674-82. PMC: 3717855. DOI: 10.2337/db13-0106. View

Tu J, Guo Y, Hong W, Fang Y, Han D, Zhang P . The Regulatory Effects of Paeoniflorin and Its Derivative Paeoniflorin-6'-O-Benzene Sulfonate CP-25 on Inflammation and Immune Diseases. Front Pharmacol. 2019; 10:57. PMC: 6370653. DOI: 10.3389/fphar.2019.00057. View

Shao Y, Xu X, Wang K, Qi X, Wu Y . Paeoniflorin attenuates incipient diabetic nephropathy in streptozotocin-induced mice by the suppression of the Toll-like receptor-2 signaling pathway. Drug Des Devel Ther. 2017; 11:3221-3233. PMC: 5687495. DOI: 10.2147/DDDT.S149504. View

10.

Jansson T, Aye I, Goberdhan D . The emerging role of mTORC1 signaling in placental nutrient-sensing. Placenta. 2012; 33 Suppl 2:e23-9. PMC: 3463762. DOI: 10.1016/j.placenta.2012.05.010. View

11.

Zhao J, Di T, Wang Y, Wang Y, Liu X, Liang D . Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion. Eur J Pharmacol. 2016; 772:131-43. DOI: 10.1016/j.ejphar.2015.12.040. View

12.

Jansson N, Rosario F, Gaccioli F, Lager S, Jones H, Roos S . Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J Clin Endocrinol Metab. 2012; 98(1):105-13. PMC: 3537112. DOI: 10.1210/jc.2012-2667. View

13.

Zhu L, Sun S, Hu Y, Liu Y . Metabolic study of paeoniflorin and total paeony glucosides from Paeoniae Radix Rubra in rats by high-performance liquid chromatography coupled with sequential mass spectrometry. Biomed Chromatogr. 2017; 32(4). DOI: 10.1002/bmc.4141. View

14.

Li P, Liu D, Liu Y, Song S, Wang Q, Chang Y . BAFF/BAFF-R involved in antibodies production of rats with collagen-induced arthritis via PI3K-Akt-mTOR signaling and the regulation of paeoniflorin. J Ethnopharmacol. 2012; 141(1):290-300. DOI: 10.1016/j.jep.2012.02.034. View

15.

Shu J, Zhang X, Han L, Zhang F, Wu Y, Tang X . Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agents. Acta Pharmacol Sin. 2018; 40(6):801-813. PMC: 6786314. DOI: 10.1038/s41401-018-0169-5. View

16.

Buchanan T, Xiang A, Page K . Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. 2012; 8(11):639-49. PMC: 4404707. DOI: 10.1038/nrendo.2012.96. View

17.

Burton G, Fowden A . The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci. 2015; 370(1663):20140066. PMC: 4305167. DOI: 10.1098/rstb.2014.0066. View

18.

Kezic A, Popovic L, Lalic K . mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?. Oxid Med Cell Longev. 2018; 2018:2640342. PMC: 6035806. DOI: 10.1155/2018/2640342. View

19.

Carreiro M, Nogueira A, Ribeiro-Oliveira A . Controversies and Advances in Gestational Diabetes-An Update in the Era of Continuous Glucose Monitoring. J Clin Med. 2018; 7(2). PMC: 5852427. DOI: 10.3390/jcm7020011. View

20.

Wang S, Zhao X, Qiao Z, Jia X, Qi Y . Paeoniflorin attenuates depressive behaviors in systemic lupus erythematosus mice. Biomed Pharmacother. 2018; 103:248-252. DOI: 10.1016/j.biopha.2018.03.149. View